Novartis Chief Executive Vas Narasimhan, facing an uproar over data manipulation involving $2.1 million gene therapy Zolgensma, pledged on Monday to tell regulators quickly if credible questions emerge in future over data integrity.
Novartis has said it knew of discrepancies in Zolgensma data it had submitted to the U.S. Food and Drug Administration before it won approval for the world's most expensive medicine in May, but delayed informing regulators until June 28 while it completed an internal investigation.
Novartis has said it knew of discrepancies in Zolgensma data it had submitted to the U.S. Food and Drug Administration before it won approval for the world's most expensive medicine in May, but delayed informing regulators until June 28 while it completed an internal investigation. "We are making a voluntary commitment to notify the FDA within five business days of receipt by our quality organisation of any credible allegation related to data integrity impacting any pending application in the Novartis Group," Narasimhan said at an investor event, adding Novartis will take a similar approach in other jurisdictions.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Eni CEO: 'You have to give energy but a different kind of energy'Claudio Descalzi was speaking to CNBC at the World Energy Congress in Abu Dhabi.
Consulte Mais informação »
Nissan CEO Saikawa ResignsNissan Motor Chief Executive Hiroto Saikawa will step down effective Sept. 16, ending a term marked by controversy over the arrest of former Chairman Carlos Ghosn.
Consulte Mais informação »
Saudi Arabia's ACWA Power to focus more on renewable energy projects: CEOACWA Power plans to focus more on renewable energy projects, lifting their share...
Consulte Mais informação »
Nissan's CEO is resigning after months of turmoil at the Japanese automakerHiroto Saikawa, who took over amid financial misconduct charges against chairman Carlos Ghosn, acknowledged an overpayment from the company last week.
Consulte Mais informação »
Nissan CEO Saikawa resigns after admitting he was improperly overpaidNissan Motor CEO Hiroto Saikawa is stepping down after an internal company investigation revealed falsified documents that boosted his compensation in 2013 by about $900,000.
Consulte Mais informação »